Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease
Launched by CHINESE ACADEMY OF MEDICAL SCIENCES, FUWAI HOSPITAL · Jun 10, 2017
Trial Information
Current as of June 09, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • stable COPD patients
- Exclusion Criteria:
- • patents with other respiratory diseases and pulmonary hypertension other than group 3 PH;
- • psychopath, addict or patients not able to coordinate;
- • patients in pregnancy or breastfeeding;
- • patients with limited life expectancy;
- • patients with contraindiction for MRI or PET;
- • patients having cerebrovascular events in 3 months;
- • unstable COPD patients
About Chinese Academy Of Medical Sciences, Fuwai Hospital
The Chinese Academy of Medical Sciences (CAMS) Fuwai Hospital is a leading institution in cardiovascular research and healthcare in China, renowned for its commitment to advancing medical knowledge and improving patient care. As a major clinical trial sponsor, Fuwai Hospital focuses on innovative therapies and interventions, leveraging its extensive resources and expertise in cardiology and related fields. The institution fosters collaboration among multidisciplinary teams of researchers and healthcare professionals, aiming to translate scientific discoveries into clinical applications effectively. With a robust regulatory framework and a dedication to ethical research practices, CAMS Fuwai Hospital plays a pivotal role in addressing critical health challenges and enhancing the quality of life for patients both nationally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials